Global Disparities in Pain Management

Friday, December 06, 2013
The Annals of Oncology recently published a supplement (2013, volume 24, supplement 11; on the results of the first global study of the availability and barriers for accessing opioids to treat cancer pain. Not surprisingly, many patients are not receiving adequate pain control because of regulatory restrictions and lack of access and availability. It is estimated that 5 billion people live in countries with little or no access to adequate pain relief.
One report in the supplement was initiated by the European Society of Medical Oncology (ESMO), working in collaboration with the European Association of Palliative Care (EAPC), the Pain and Policies Study Group at the University of Wisconsin Carbone Cancer Center in Madison, the Union for International Cancer Control (UICC), and the World Health Organization (WHO). These groups collaborated with local and regional partners to collect data on access and barriers. The survey evaluated 79 countries and 25 Indian states, representing 87% of the global population. In Africa, Asia, the Caribbean, Latin America, and the Middle East, the ESMO and its partners assessed the availability of the 7 opioids designated to be essential for the relief of cancer pain by the WHO Model List of Essential Medicines and the International Association for Hospice and Palliative Care: codeine, oral oxycodone, transdermal fentanyl, immediate- and slow-release oral morphine, injectable morphine, and oral methadone. Many disparities between developed and developing countries were observed. Four countries (USA, Australia, Canada, and the UK) use 69% of the world’s opioids, and developing countries used just 7%. This of course does not mean that opioids are being over-prescribed in the USA. Instead, the data suggest that they are being under-utilized in developing countries because of problems with accessing opioids and regulations that while well-intended, are actually preventing patients in developing countries from receiving the pain control that they need—and deserve to receive. 

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.